Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation THT 2026

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Presenter: Barry Borlaug

March 02, 2026

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Presentation THT 2024

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

Presenter: Jennifer Ho

March 04, 2024

Presentation THT 2024

The OBESITY-HF Connection: Time to Attack This Head-on

Presenter: Barry Borlaug

March 04, 2024

Presentation THT 2023

Does Obesity Paradox Exist in Cardiogenic Shock?

Presenter: Maya Guglin

March 22, 2023

Presentation THT 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presenter: Sheldon Litwin

March 21, 2023

Presentation THT 2023

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Presenter: Rafail Beshai

March 20, 2023

Advertisement

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Inflammation and HFpEF: Rationale for HERMES

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Obesity: Assessing the Weight of the Evidence

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

The OBESITY-HF Connection: Time to Attack This Head-on

Does Obesity Paradox Exist in Cardiogenic Shock?

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content